Announcements Trials
Browse Landscape

Phase

Phase NA 2Phase 3 2Phase 1/2 2Phase 2 1

Status

Withdrawn 1Unknown 1

Sponsor Class

OTHER 1NIH 1

Study Type

Interventional 2

Sponsor

Cancer Type

Other 2Gastrointestinal 2Gynecologic 1

Conditions

Mucositis 17Pain 12Opioid-Induced Constipation 12Constipation 12Obesity 11Sexual Dysfunction, Physiological 9Head and Neck Neoplasms 8Neoplasms 7Breast Neoplasms 7Polycystic Ovary Syndrome 4Bronchiolitis Obliterans Syndrome 4Weight Loss 3Prostatic Neoplasms 3Intestinal Diseases 3Stomatitis 2Squamous Cell Carcinoma of Head and Neck 2Sexuality 2Prediabetic State 2Intestinal Obstruction 2Hyperinsulinism 2Fatigue 2Dyspnea 2Xerostomia 1Wilms Tumor 1Vulvar Neoplasms 1Vaginal Neoplasms 1Uterine Cervical Neoplasms 1Urinary Incontinence 1Tongue Neoplasms 1Testicular Neoplasms 1

Interventions

Naloxone 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Phase 3 × Intestinal Obstruction × Other × Clear all
NCT00020605 2018-12-13

Naloxone in Treating Constipation in Patients Who Are Receiving Opioids for Chronic Pain

National Cancer Institute (NCI)

Phase 3 Unknown
Other

Constipation, Intestinal Obstruction

NCT01473290 2016-07-06

Probiotic Therapy in Preventing Gastrointestinal Complications in Patients Undergoing Chemotherapy and Pelvic Radiation Therapy

Alliance for Clinical Trials in Oncology

Phase 3 Withdrawn
Other

Constipation, Diarrhea, Fatigue, Intestinal Obstruction

Data powered by HemOnc (CC BY 4.0) Colophon âš¡